Data updated: Mar 10, 2026
ISOPROTERENOL HYDROCHLORIDE
ISOPROTERENOL HYDROCHLORIDE
Approved 1956-03-09
21
Indications
--
Phase 3 Trials
70
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1956-03-09
- Routes
- INJECTION, INHALATION
- Dosage Forms
- INJECTABLE, AEROSOL, METERED, SOLUTION
Companies
Pfizer AVET LIFESCIENCES ZYDUS PHARMS AMRING PHARMS PHARMOBEDIENT DEVA HOLDING AS Hikma ALPHARMA US PHARMS PARKE DAVIS EUGIA PHARMA AM REGENT PENN LIFE GLAND INTL MEDICATION ARMOUR PHARM NEXUS AMPHASTAR PHARMS INC SOMERSET THERAPS LLC 3M Baxter DEY Cipla MICRO LABS ABRAXIS PHARM AMNEAL
Active Ingredient: ISOPROTERENOL HYDROCHLORIDE
Website: ↗
ISOPROTERENOL HYDROCHLORIDE Approval History
Loading approval history...
What ISOPROTERENOL HYDROCHLORIDE Treats
21 FDA approvalsOriginally approved for its first indication in 1956 . Covers 21 distinct patient populations.
- Other (21)
Other
(21 approvals)- • Approved indication (Mar 1956)
- • Approved indication (Nov 1974)
- • Approved indication (Jul 1975)
- • Approved indication (Jan 1976)
- • Approved indication (Aug 2017)
- • Approved indication (Jun 2018)
- • Approved indication (Jun 2018)
- • Approved indication (Oct 2018)
- • Approved indication (Jun 2019)
- • Approved indication (Feb 2021)
- • Approved indication (Feb 2021)
- • Approved indication (May 2021)
- • Approved indication (Nov 2021)
- • Approved indication (Sep 2022)
- • Approved indication (Sep 2022)
- • Approved indication (Oct 2022)
- • Approved indication (Apr 2023)
- • Approved indication (Apr 2023)
- • Approved indication (Aug 2024)
- • Approved indication (Oct 2024)
- • Approved indication (Dec 2025) New
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ISOPROTERENOL HYDROCHLORIDE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.